Penetrium Bioscience Inc. (KOSDAQ:187660)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,510
-750 (-5.66%)
At close: Apr 28, 2026

Penetrium Bioscience Revenue

In the year 2024, Penetrium Bioscience had annual revenue of 9.74B KRW, down -29.33%.

Revenue
9.74B
Revenue Growth
-29.33%
P/S Ratio
70.30
Revenue / Employee
60.91M
Employees
160
Market Cap
685.09B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20249.74B-4.05B-29.33%
Dec 31, 202313.79B-1.09B-7.34%
Dec 31, 202214.88B904.78M6.47%
Dec 31, 202113.98B857.61M6.54%
Dec 31, 202013.12B2.91B28.55%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
DreamCIS 66.63B
HLB bioStep 74.05B
P&K Skin Research Center 22.78B
WOOJUNG BIO 37.59B
DT&CRO CO. 47.75B
C&R Research 64.98B
SLS BIO 3.98B
BioInfra 23.15B
Revenue Rankings